Omid Shoraka

Omid Shoraka

Auto-generated profile, based on publicly available information

Omid Shoraka

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2024 in Journal of Neuroimaging
Verified
Journal Article
Open access
OSOmid Shoraka
Omid Shoraka
MSMashaal Syed
Mashaal Syed
SMShreya Mandloi
Shreya Mandloi
STSara Thalheimer
Sara Thalheimer
SKSara Naghizadeh Kashani
Sara Naghizadeh Kashani
MAMahdi Alizadeh
Mahdi Alizadeh
Background and Purpose: Neuropathic pain (NP) is a debilitating condition following spinal cord injury (SCI). The role of periaqueductal gray (PAG) in NP development following SCI remains underexplored. Using resting‐state functional MRI (rsfMRI), our study aimed to demonstrate the alterations in functional connectivity (FC) of PAG in NP following SCI.Methods: Ten SCI patients (SCI + NP, n = 7, and SCI − NP, n = 3), alongside 10 healthy controls (HCs), were enrolled. rsfMRI was conducted followed by seed‐to‐voxel analysis using PAG as the seed region and then group‐based analysis comprising three groups (SCI + NP, SCI − NP, and HC). Age and gender were considered as confounding variables.Results: Compared to HCs, SCI + NP demonstrated decreased FC between PAG and right insula, right frontal orbital cortex, right pallidum, dorsal raphe nucleus (DRN), red nuclei (RN), substantia nigra (SN), and ventral posterolateral (VPL) thalamic nuclei. Compared to SCI − NP, SCI + NP demonstrated increased FC between PAG and posterior cingulate cortex (PCC), hippocampus, cerebellar vermis lobules IV and V, and thalamic structures (posterior and lateral pulvinar, the mediodorsal nuclei, and the ventral lateral nuclei). Additionally, decreased FC between the PAG and VPL, geniculate bodies, intralaminar nuclei of thalamus, DRN, RN, SN, and prefrontal cortex was observed in this comparison.Conclusions: Altered FC between PAG and right anterior insula, VPL, DRN, RN, SN, cerebellar vermis lobules IV and V, frontal cortex, and PCC was associated with NP sequelae of SCI. Additionally, SCI was independently associated with decreased FC between PAG and right posterior insula, cerebellar lobules IV and V, and cerebellar vermis lobules III, IV, and V.

29 April 2025 in Interventional Neuroradiology
Verified
Journal Article
Closed access
DGDiwas Gautam
Diwas Gautam
OSOmid Shoraka
Omid Shoraka
SNSarah Nguyen
Sarah Nguyen
MBMichael T Bounajem
Michael T Bounajem
ASAaron Shoskes
Aaron Shoskes
RGRamesh Grandhi
Ramesh Grandhi
Background: Cerebral venous sinus thrombosis (CVST) is rare but potentially life-threatening. Although systemic anticoagulation is the primary treatment, endovascular thrombectomy (EVT) or thrombolysis may be considered for refractory cases. Considering advanced techniques and device technology, we undertook an updated systematic review and meta-analysis to evaluate clinical and radiographic outcomes for treating CVST. Methods: We searched PubMed and EMBASE for studies describing CVST patients treated with EVT. Presenting symptoms, procedural details, and clinical and radiographic outcomes were analyzed. Random-effects models were generated to calculate pooled proportions of clinical and radiographic outcome variables. Results: We analyzed 26 studies comprising 273 patients (mean age 37 years, 57.7% female). Preprocedural intracranial hemorrhage was present in 167/243 (67.1%) patients. Endovascular thrombectomy techniques included aspiration thrombectomy alone (29.3%), aspiration plus stent retriever (19%), stent retriever alone (12.5%), balloon/catheter maceration (6.6%), and AngioJet rheolytic system (32.6%). Random-effects model indicated that 37% of patients had complete recanalization and 57% had partial recanalization. The model indicated that 79% of patients had a good clinical outcome (modified Rankin Scale score 0–2) at last follow-up. There were no statistically significant differences between modern systems (stent retriever and/or aspiration) and older systems (rheolytic thrombectomy and catheter maceration). Aspiration alone yielded a significantly higher frequency of good clinical outcomes compared with the combined technique (83.8% vs. 61.5%, p = 0.004). Conclusion: Endovascular thrombectomy for CVST refractory to systemic anticoagulation achieved high recanalization rates, favorable outcomes, and low procedural complication rates. Modern and older techniques exhibited similar safety and efficacy. These findings support EVT as an effective treatment option.

13 May 2025 in Interventional Neuroradiology
Verified
Journal Article
Closed access
OSOmid Shoraka
Omid Shoraka
RGRamesh Grandhi
Ramesh Grandhi
SMSamantha Miller
Samantha Miller
JRJoanna Roy
Joanna Roy
VJVinay Jaikumar
Vinay Jaikumar
AHAmeer E. Hassan
Ameer E. Hassan
Background: Intracranial atherosclerotic disease (ICAD) is a leading cause of ischemic stroke. The Medtronic Resolute Onyx Zotarolimus-eluting stents (RO-ZES) are promising in preventing stroke recurrence compared with medical management (MM) and percutaneous angioplasty and stenting (PTAS) at both 30-day and one-year follow-ups. We evaluated long-term outcomes for patients treated with RO-ZES, PTAS, or MM. Methods: A retrospective multicenter study was conducted including patients who underwent RO-ZES stenting for symptomatic ICAD between March 2018 and May 2023, with follow-up through October 2024. Propensity score-matched control groups, representing MM and PTAS, were derived from the SAMMPRIS trial. Primary outcomes included recurrence rates of transient ischemic attack, stroke, intracerebral hemorrhage (ICH), and mortality. Time-to-event after intervention was evaluated. Results: Patients who underwent stenting with RO-ZES and two propensity-matched cohorts from the SAMMPRIS trial who underwent MM and PTAS were included. Mean follow-up was 27.9 ± 17.0 months. The RO-ZES group demonstrated significantly fewer recurrent strokes (11.3%) compared with MM (27.0%) and PTAS (27.8%) ( p = .003). The MM group experienced the lowest recurrence rate of ICH (0.9%) ( p = .018). Multivariable regression revealed that RO-ZES experienced lower odds of recurrent strokes (OR = .40, 95% CI [0.17–0.92], p = .031) than PTAS throughout follow-up. Multivariable Cox regression demonstrated that RO-ZES stenting lowered the hazard of recurrent strokes compared with PTAS (hazard ratio = .36, 95% CI [0.16–0.80], p = .012). Conclusion: Treatment of severe, symptomatic ICAD using RO-ZES was associated with lower odds of recurrent strokes compared with PTAS in this long-term follow-up study. Further prospective trials comparing MM with novel stent technologies are necessary.

29 April 2023 in Addiction & Health
Verified
Journal Article
Open access
PDF file
ANAli Beheshti Namdar
Ali Beheshti Namdar
MAMina AkbariRad
Mina AkbariRad
MFMohammadreza Farzaneh Far
Mohammadreza Farzaneh Far
MAMitra Ahadi
Mitra Ahadi
SHSeyed Mousalreza Hosseini
Seyed Mousalreza Hosseini
AGAmirAli Moodi Ghalibaf
AmirAli Moodi Ghalibaf
Background: As a common digestive disorder, choledocholithiasis can have serious consequences, including death. Given that opioids have been shown to contribute to the spasm of Oddi’s sphincter, which results in biliary stasis in the common bile duct (CBD), it is likely that opioids can also raise the prevalence of choledocholithiasis. In this regard, this study aimed to investigate how common opium addiction was among choledocholithiasis patients in Mashhad, Iran. Methods: The current retrospective observational study was conducted on 599 patients with choledocholithiasis who underwent endoscopic retrograde cholangiopancreatography (ERCP), utilizing information gathered at the Ghaem hospital in Mashhad, Iran, between 2011 and 2015. Patient data were collected from files and records using certain criteria such as gender, opium addiction, hepatic enzymes (AST, ALT, ALP), plasma levels of total bilirubin, and direct bilirubin. The size of the CBD stones as well as the correlation between the gallbladder and CBD stones were calculated. Findings: From among 599 patients included, 345 (57.6%) were female and 254 (42.4%) were male. Moreover, 195 patients (32.2%) had opiate addictions. The size of the CBD stone was correlated with the patient’s age (r=0.17, P=0.001). The average stone measured 12.22±3.32 mm. There were notable differences in the mean size of the CBD stone (P<0.001) between addicted and non-addicted cases; specifically, the mean CBD stone size in addicted cases was 12.715.13 mm while it was 12.34.33 mm in non-addicted cases. Conclusion: This study showed patients with CBD stones have a higher rate of opium addiction compared to the general population, indicating a possible link between the two conditions.

25 November 2025 in Interventional Neuroradiology
Verified
Journal Article
Open access
DBDanielle C Brown
Danielle C Brown
MKManisha Koneru
Manisha Koneru
JKJane Khalife
Jane Khalife
HSHamza A Shaikh
Hamza A Shaikh
JSJoshua Santucci
Joshua Santucci
DTDaniel A Tonetti
Daniel A Tonetti
Background: Balloon guide catheters (BGCs) have been associated with higher rates of first pass effect (FPE) in endovascular thrombectomy. Large-bore aspiration catheters (ACs) placed at the face of the embolus may mimic the flow arrest effect seen with BGCs; combined use and its effect on FPE have not been previously well-studied. This study aims to evaluate the impact of this dual-device strategy on achieving FPE. Methods: We conducted a retrospective cohort study across three sites (2018–2024). A multicenter registry was queried for adult patients with anterior circulation acute ischemic stroke treated with thrombectomy. The primary outcome was rate of FPE (modified Treatment in Cerebral Infarction (mTICI) 2C/3 on the first pass). Multivariable logistic regressions for likelihood of FPE were performed. Results: 973 patients were included, with a median age of 69 years (IQR 59–79). BGCs were used in 26.3%. Large-bore ACs were used in 68.7%. In most cases, large-bore ACs were used without a BGC (BGC-: 77.5% vs. BGC+: 43.8%, P < .001). FPE was achieved in 3—0.6% of procedures. BGC usage was significantly associated with FPE (aOR: 1.94, 95% CI: 1.01–3.72, P = .04). When sub-stratified by BGC use, large-bore AC use was found to be significantly associated with FPE only when a BGC was not used (aOR: 3.34, 95% CI: 1.01–12.14, P = .04). Conclusion: BGC use is associated with an increased likelihood of FPE; when BGCs were not used, large-bore ACs were significantly associated with a higher likelihood of FPE. These findings are important when considering which tools contribute to successfully achieving FPE.

18 February 2026 in Operative Neurosurgery
Verified
Journal Article
Closed access
CCCamron Chugg
Camron Chugg
OSOmid Shoraka
Omid Shoraka
DGDiwas Gautam
Diwas Gautam
DBDavid Botros
David Botros
CWCaitlyn Wandvik
Caitlyn Wandvik
RGRamesh Grandhi
Ramesh Grandhi
BACKGROUND AND OBJECTIVES: Frailty scoring systems are increasingly used to assess patient vulnerability and predict surgical outcomes. Our objective was to compare the predictive performance of the revised Risk Analysis Index (RAI-rev) and the Charlson Comorbidity Index (CCI) in patients undergoing treatment for chronic subdural hematoma (cSDH). METHODS: We conducted a retrospective multicenter study of patients treated with surgical and/or endovascular intervention for cSDH between January 2019 and July 2024. Baseline demographics, comorbidities, frailty scores, and radiographic characteristics were collected. The primary outcome measures were good clinical outcome at the last follow-up (modified Rankin Scale score ≤2) and 30-day mortality. Multivariable regression models were used to assess predictive associations, and receiver operating characteristic analysis was used to evaluate model discrimination. Optimal cutoff scores were determined using Youden's index. RESULTS: RAI-rev was independently associated with 30-day mortality (odds ratio = 1.05, P = .017) and good clinical outcomes at last follow-up (odds ratio = 0.95, P < .001). In addition, RAI-rev demonstrated superior discrimination compared with CCI for predicting both 30-day mortality (area under the curve 0.857 vs 0.839, respectively) and good clinical outcome (area under the curve 0.767 vs 0.739, respectively). A RAI-rev cutoff score ≥28 identified patients at higher risk, with 30-day mortality of 7.8% vs 2.0% ( P = .007) and favorable outcomes in 64.8% vs 86.9% ( P < .001). CONCLUSION: RAI-rev outperforms CCI in predicting outcomes for patients undergoing surgical and/or endovascular treatment for cSDH. Including RAI-rev during preoperative evaluation may enhance risk stratification and guide treatment planning, including consideration of less invasive interventions in frail patients. Furthermore, integrating RAI-rev into future clinical trials studying patients with cSDH may allow for better understanding of frailty metrics and capture of clinical variables that can affect patient outcomes.